Physician profile
David Lo
NPI 1063671493
$12,639.78
in general payments reported to CMS, 2019-2025
21 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,128 · 2020: $235 · 2021: $767 · 2022: $1,428 · 2023: $3,743 · 2024: $2,271 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,389 · Travel and Lodging: $1,885 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,388.57 |
| Travel and Lodging | $1,884.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,178.85 | 2023-2025 | |
| Allergan, INC. | $3,673.39 | 2019-2022 | |
| Mentor Worldwide LLC | $3,022.48 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Memorygel Breast Implant |
| Rti Surgical, INC | $491.40 | 2022-2024 | |
| Revance Therapeutics, INC. | $277.69 | 2024-2025 | Daxxify |
| Tela Bio, INC. | $186.39 | 2020-2022 | |
| Sientra, INC. | $146.64 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $121.82 | 2023 | Exparel |
| Bard Peripheral Vascular, INC. | $115.11 | 2021 | |
| Medtronic, INC. | $106.73 | 2023 | Dextile |
| Motiva USA, LLC | $90.47 | 2025 | |
| Merz North America, INC. | $41.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.14 | 2022 | |
| Organogenesis INC. | $22.94 | 2021 | |
| Biowound Solutions, INC. | $22.31 | 2025 | Bio-Connekt |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $21.14 | 2022 | |
| Solventum Corporation | $20.17 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Solta Medical, A Division of Bausch Health US, LLC | $18.95 | 2022 | |
| Kci USA, INC. | $18.71 | 2021 | |
| Philips North America LLC | $14.04 | 2023 | |
| Stryker Corporation | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.